VRPX
Virpax Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
1320.6%
Return on equity
-775.7%
Return on assets
1322.0%
Return on invested capital
0.00x
Asset turnover
-$16.7M
Cash from operations
$0.36
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2024